HLA-A*01 allele: A risk factor for dengue haemorrhagic fever in Brazil's population

Memorias do Instituto Oswaldo Cruz

Volumn 107, Issue 2, 2012, Pages 224-230

  Monteiro, Sérgio Pereira ^a   do Brasil, Pedro Emmanuel Alvarenga Americano ^b   Cabello, Giselda Maria Kalil ^a   de Souz, Rogério Valls ^b   Brasil, Patrícia ^b   Georg, Ingebourg ^b   Cabello, Pedro Hernan ^a   de Castro, Liane ^b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Funda??o Oswaldo Cruz   (Brazil)

Author keywords

Brazil; Dengue fever; Dengue haemorrhagic fever; HLA typing; HLA A

Indexed keywords

HLA A1 ANTIGEN;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; BRAZIL; CASE CONTROL STUDY; CHILD; DENGUE; FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; MALE; MIDDLE AGED; PRESCHOOL CHILD; RISK FACTOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; BRAZIL; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DENGUE HEMORRHAGIC FEVER; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HLA-A1 ANTIGEN; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; YOUNG ADULT;

EID: 84857927782     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762012000200012     Document Type: Article

References (54)

1. Alves-Silva J, da Silva Santos M, Guimarães PE, Ferreira AC, Bandelt HJ, Pena SD, Prado VF 2000. The ancestry of Brazilian mtDNA lineages. Am J Hum Genet 67: 444-461.
2. Appanna R, Ponnampalavanar S, Lum Chai See L, Sekaran SD 2010. Susceptible and protective HLA class 1 alleles against dengue fever and dengue hemorrhagic fever patients in a Malaysian population. PLoS ONE 28: e13029.
3. Barbosa da Silva Jr J, Siqueira Jr JB, Coelho GE, Vilarinhos PT, Pimenta Jr FG 2002. Dengue in Brazil: current situation and prevention and control activities. Epidemiol Bull 23: 3-6.
4. Bettinotti MP, Mitsuishi Y, Bibee K, Lau M, Terasaki PI 1997. Comprehensive method for the typing of HLA-A, B and C alleles by direct sequencing of PCR products obtained from genomic DNA. J Immunother 20: 425-430.
5. Blackwell JM, Jamieson SE, Burgner D 2009. HLA and infectious diseases. Clin Microbiol Rev 22: 370-385.
6. Chaturvedi U, Nagar R, Shrivastava R 2006. Dengue and dengue haemorrhagic fever: implications of host genetics. FEMS Immunol Med Microbiol 47: 155-166.
7. Chiewsilp P, Scott RM, Bhamarapravati N 1981. Histocompatibility antigens and dengue hemorrhagic fever. Am J Trop Med Hyg 30: 1100-1105.
8. Coffey LL, Mertens E, Brehin AC, Fernandez-Garcia MD, Amara A, Despres P, Sakuntabhai A 2009. Human genetic determinants of dengue virus susceptibility. Microbes Infect 11: 143-156.
9. de la C Sierra B, Kouri G, Guzman MG 2007. Race: a risk factor for dengue hemorrhagic fever. Arch Virol 152: 533-542.
10. Diamond MS, Edgil D, Roberts TG, Lu B, Harris E 2000. Infection of human cells by dengue virus is modulated by different cell types and viral strains. J Virol 74: 7814-7823.
11. Falcon-Lezama JA, Ramos C, Zuniga J, Juarez-Palma L, Rangel- Flores H, Garcia-Trejo AR, Acunha-Alonzo V, Granados J, Vargas-Alarcon G 2009. HLA class I and II polymorphisms in Mexican Mestizos patients with dengue fever. Acta Trop 112: 193-197.
12. Fink J, Gu F, Vasudevan SG 2006. Role of T cells, cytokines and antibody in dengue fever and dengue haemorrhagic fever. Rev Med Virol 16: 263-275.
13. Gerlach JA 2002. Human lymphocyte antigen molecular typing: how to identify the 1250+ alleles out there. Arch Pathol Lab Med 126: 281-284.
14. Gubler DJ 2002. Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol 10: 100-103.
15. Gubler DJ 2006. Dengue/dengue haemorrhagic fever: history and current status. Novartis Found Symp 277: 3-16.
16. Gubler DJ, Suharyono W, Tan R, Abidin M, Sie A 1981. Viraemia in patients with naturally acquired dengue infection. Bull World Health Organ 59: 623-630.
17. Gunther J, Ramirez-Palacio LR, Perez-Ishiwara DG, Salas-Benito JS 2009. Distribution of dengue cases in the state of Oaxaca, Mexico, during the period 2004-2006. J Clin Virol 45: 218-222.
18. Guzman MG, Kouri G 2002. Dengue: an update. Lancet Infect Dis 2: 33-42.
19. Guzman MG, Kouri G 2008. Dengue haemorrhagic fever integral hypothesis: confirming observations, 1987-2007. Trans R Soc Trop Med Hyg 102: 522-523.
20. Hall P 1999. BioEdit: a user-friendly biological sequence alignment editor and analysis program for windows 95/98/NT. Nucl Acids Symp 41: 95-98.
21. Halstead SB 1970. Observations related to pathogenesis of dengue hemorrhagic fever. VI. Hypotheses and discussion. Yale J Biol Med 42: 350-362.
22. Halstead SB 1980. Dengue haemorrhag ic fever - a public health problemand a field for research. Bull World Health Organ 58: 1-21.
23. Halstead SB 1988. Pathogenesis of dengue: challenges to molecular biology. Science 239: 476-481.
24. Halstead SB 2006. Dengue in the Americas and southeast Asia: do they differ? Rev Panam Salud Publica 20: 407-415.
25. Halstead SB 2007. Dengue. Lancet 370: 1644-1652.
26. Halstead SB, Streit TG, Lafontant JG, Putvatana R, Russell K, Sun W, Kanesa-Thasan N, Hayes CG, Watts DM 2001. Haiti: absence of dengue hemorrhagic fever despite hyperendemic dengue virus transmission. Am J Trol Med Hyg 65: 180-183.
27. Henchal EA, Putnak JR 1990. The dengue viruses. Clin Microbiol Rev 3: 376-396.
28. Kliks SC, Nisalak A, Brandt WE, Wahl L, Burke DS 1989. Antibodydependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am J Trop Med Hyg 40: 444-451.
29. LaFleur C, Granados J, Vargas-Alarcon G, Ruiz-Morales J, Villarreal- Garza C, Higuera L, Hernandez-Pacheco G, Cutino-Moguel T, Rangel H, Figueroa R, Acosta M, Lazcano E, Ramos C 2002. HLA-DR antigen frequencies in Mexican patients with dengue virus infection: HLA-DR4 as a possible genetic resistance factor for dengue hemorrhagic fever. Hum Immunol 63: 1039-1044.
30. Loke H, Bethell DB, Phuong CX, Dung M, Schneider J, White NJ, Day NP, Farrar J, Hill AV 2001. Strong HLA class I - restricted T cell responses in dengue hemorrhagic fever: a double-edged sword? J Infect Dis 184: 1369-1373.
31. Moraes ME, Fernandez-Vina M, Salatiel I, Tsai S, Moraes JR, Stastny P 1993. HLA class II DNA typing in two Brazilian populations. Tissue Antigens 41: 238-242.
32. MS - Ministério da Saúde 2011. [homepage on the internet]. Tabulação de dados. Dengue - Notificações registradas no sistema de informação de agravos de notificação - SinanNet. [cited 2011 September 08]. Available from: www.dtr2004.saude.gov.br/sinanweb/index.php.
33. Narro-Robles J, Gomez-Dantes H 1995. Dengue in Mexico: a priority problem of public health. Salud Publica Mex 37 (Suppl.): 12-20.
34. Nguyen TP, Kikuchi M, Vu TQ, Do QH, Tran TT, Vo DT, Ha MT, Vo VT, Cao TP, Tran VD, Oyama T, Morita K, Yasunami M, Hirayama K 2008. Protective and enhancing HLA alleles, HLADRB1* 0901 and HLA-A*24 for severe forms of dengue virus infection, dengue hemorrhagic fever and dengue shock syndrome. PLoS Negl Trop Dis 2: 304.
35. Nimmannitya S 1987. Clinical spectrum and management of dengue haemorrhagic fever. Southeast Asian J Trop Med Public Health 18: 392-397.
36. Nisalak A, Endy TP, Nimmannitya S, Kalayanarooj S, Thisayakorn U, Scott RM, Burke DS, Hoke CH, Innis BL, Vaughn DW 2003. Serotype-specific dengue virus circulation and dengue disease in Bangkok, Thailand from 1973 to 1999. Am J Trop Med Hyg 68: 191-202.
37. Nogueira RM, de Araujo JM, Schatzmayr HG 2007. Dengue viruses in Brazil, 1986-2006. Rev Panam Salude Publica 22: 358-363.
38. Nogueira RM, Miagostovich MP, de Filippis AM, Pereira MA, Schatzmayr HG 2001. Dengue virus type 3 in Rio de Janeiro, Brazil. Mem Inst Oswaldo Cruz 96: 925-926.
39. Otto TD, Vasconcellos EA, Gomes LH, Moreira AS, Degrave WM, Mendonca-Lima L, Alves-Ferreira M 2008. ChromaPipe: a pipeline for analysis, quality control and management for a DNA sequencing facility. Genet Mol Res 7: 861-871.
40. Paradoa Perez ML, Trujillo Y, Basanta P 1987. Association of dengue hemorrhagic fever with the HLA system. Haematologia (Budap) 20: 83-87.
41. Pinheiro FP, Corber SJ 1997. Global situation of dengue and dengue haemorrhagic fever and its emergence in the Americas. World Health Stat Q 50: 161-169.
42. Polizel JR, Bueno D, Visentainer JE, Sell AM, Borelli SD, Tsuneto LT, Dalalio MM, Coimbra MT, Moliterno RA 2004. Association of human leukocyte antigen DQ1 and dengue fever in a white Southern Brazilian population. Mem Inst Oswaldo Cruz 99: 559-562.
43. Santamaria P, Lindstrom AL, Boyce-Jacino MT, Myster SH, Barbosa JJ, Faras AJ, Rich SS 1993. HLA class I sequence-based typing. Hum Immunol 37: 39-50.
44. Shiina T, Hosomichi K, Inoko H, Kulski JK 2009. The HLA genomic loci map: expression, interaction, diversity and disease. J Hum Genet 54: 15-39.
45. Sierra B, Alegre R, Perez AB, Garcia G, Sturn-Ramirez K, Obasanjo O, Aguirre E, Alvarez M, Rodriguez-Roche R, Valdes L, Kanki P, Guzman MG 2007. HLA-A, -B, -C and -DRB1 allele frequencies in Cuban individuals with antecedents of dengue 2 disease: advantages of the Cuban population for HLA studies of dengue virus infection. Hum Immunol 68: 531-540.
46. Stephens HA, Klaythong R, Sirikong M, Vaughn DW, Green S, Kalayanarooj S, Endy TP, Libraty DH, Nisalak A, Innis BL, Rothman AL, Ennis FA, Chandanayingyong D 2002. HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais. Tissue Antigens 60: 309-318.
47. Teixeira MG, Costa M da C, Barreto F, Barreto ML 2009. Dengue: twenty-five years since reemergence in Brazil. Cad Saude Publica 25 (Suppl. 1): S7-S18.
48. Teixeira MG, Costa MC, Coelho G, Barreto ML 2008. Recent shift in age pattern of dengue hemorrhagic fever, Brazil. Emerg Infect Dis 14: 1663.
49. Thisyakorn U, Nimmannitya S 1993. Nutritional status of children with dengue hemorrhagic fever. Clin Infect Dis 16: 295-297.
50. Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, Suntayakorn S, Endy TP, Raengsakulrach B, Rothman AL, Ennis FA, Nisalak A 2000. Dengue viremia titer, antibody response pattern and virus serotype correlate with disease severity. J Infect Dis 181: 2-9.
51. Westaway EG, Block J 1997. Taxonomy and evolutionary relationships of flaviviruses. In DJ Gubler, G Kuno, Dengue and dengue hemorrhagic fever, CAB International, London, p. 147-173.
52. WHO - World Health Organization 1997. Dengue haemorrhagic fever: diagnosis, prevention and control, 2nd ed., WHO, Geneva, 8 pp.
53. WHO - World Health Organization 2009. Dengue: guidelines for diagnosis, treatment, prevention and control. Available from: www.whqlib.doc.who.int/publications/2009/9789241547871_eng.pdf.
54. Zagne SM, Alves VG, Nogueira RM, Miagostovich MP, Lampe E, Tavares W 1994. Dengue haemorrhagic fever in the state of Rio de Janeiro, Brazil: a study of 56 confirmed cases. Trans R Soc Trop Med Hyg 88: 677-679.